Convergence: Marks admits 'knucklehead' messaging missteps with bivalent boosters, touts RWE for vaccines
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyEuropeNorth AmericaProduct LifecycleRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyEuropeNorth AmericaProduct Lifecycle